MARKER THERAPEUTICS
Marker Therapeutics is a clinical stage immuno-oncology company focused on developing adoptive non-gene modified T cell therapies for the treatment of hematologic malignancies such as Acute Myeloid Leukemia, Lymphoma, and Multiple Myeloma. Marker’s MultiTAA technology selectively expands non-engineered T cells, enhancing them with the ability to kill tumor cells by targeting multiple tumor-associated antigens simultaneously to prevent immune escape and generate durable immunity. Patient/donor T cells are not genetically modified and therefore the cost of generating Marker’s therapies is significantly reduced.
MARKER THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
1992-01-01
Address:
Minneapolis, Minnesota, United States
Country:
United States
Website Url:
http://www.markertherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(713) 400-6400
Email Addresses:
[email protected]
Total Funding:
69.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Feldan Therapeutics
Feldan Therapeutics has developed a patented peptide-based technology platform.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-05-15 | TapImmune | TapImmune acquired by Marker Therapeutics | N/A |
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Marker Therapeutics
Official Site Inspections
http://www.markertherapeutics.com Semrush global rank: 8.02 M Semrush visits lastest month: 388
- Host name: hwsrv-245137.hostwindsdns.com
- IP address: 23.254.209.175
- Location: Seattle United States
- Latitude: 47.4902
- Longitude: -122.3004
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98168
